Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic asthma.

Maverick Capital

Population Health Partners

Access Biotechnology

ARCH Venture Partners

Google Ventures

Sanofi

Saturn Partners

Bain Capital Life Sciences

AreteiaTx

“I am excited that Dan has been appointed to our board,” said Jorge Bartolome, President and Chief Executive Officer of Areteia. “He is an incredibly accomplished executive whose depth of biotech experience, proven leadership and scientific expertise will be invaluable to me and the Board of Directors as we focus on delivering on the Company’s strategy and further advancing the Phase III program for dexpramipexole, the first potential oral drug for eosinophilic asthma.”

Areteia Therapeutics Announces Additional $75MM in Series A Financing for Oral Dexpramipexole in Eosinophilic Asthma - We are proud to announce that this will support significant expansion of the existing program, including adding clinical development in Japan along with several additional global markets, expansion of manufacturing activities and additional life-cycle management including development of a once-daily formulation.
Viking Global Investors and Marshall Wace to join the syndicate. More information here: https://lnkd.in/eUBs-de8

We are pleased to announce that results from the phase II EXHALE-1 study of oral dexpramipexole in eosinophilic asthma have been published online in the Journal of Allergy and Clinical Immunology. 

Jefferies Healthcare Conference (@Marriott Marquis in NYC) 

7-9th June 2023

Please come and meet Jorge Bartolome our CEO, Chris Courts our CFO, and Eric Bradford our CMO. We are presenting Wednesday, June 7th at 4:00-4:25 PM in Track 9.

We look forward to seeing you, and discussing all things eosinophilic asthma.

https://lnkd.in/gFfcbnWw

#healthcare #asthma #eosinophils


Developer of therapeutics for the treatment of neuropsychiatric disorders.

Upstream Bio

Developer of therapeutics for the treatment of asthma and other respiratory conditions.

Kinaset Therapeutics

Biotechnology company focused on developing innovative treatments for cognitive impairment and other neurological conditions.

Kither Biotech

Company specializing in therapeutics for respiratory conditions.

Aer Therapeutics

Biopharmaceutical company focused on developing treatments for respiratory diseases.

Verona Pharma

Areteia Therapeutics is a biotechnology company focused on developing innovative treatments for cognitive impairment associated with neuropsychiatric conditions.

Head of Policy and Partnerships

Partner

Director

Partner at Population Health Partners

Tamsin Berry

Chief Information Officer

Chief Digital Officer

Executive Director of Data, Insights and Statistics at NHS Digital

National Provider Support Director

Head of Security and Resilience Programme Management

Southern Programme for IT (SPfIT) Delivery Director

National Programme Office Director

Choose and Book Programme Head

Consultant

Chief Digital Officer at Population Health Partners

Tom Denwood

Chief Development Officer

Director of the Board and Chair of the Compensation Committee

Chief Development Officer MDCO

Executive Vice President, Chief Development Officer

Senior Vice President Global Innovation Group Leader

Senior Vice President, ACC GIG Health Science Leader

Director of the Board and Chair of the Audit Committee

Vice President, Head of Development

Chairman of the Board and Member of the Audit Committee

Vice President, Innovation Leader, Research & Development

Senior Director Clinical Development & European Medical Affairs

Global Alliance Director

Life Cycle Leader Transplantation

International Medical Manager Transplantation

Country Medical Manager Transplantation

Postdocteral Fellow

Postdoctoral Fellow

Laboratory Technician

Peter Wijngaard

V.P. Global Head of Quality

Principal

Vice President Quality Assurance

Senior Director Operations

Lex Kay

Senior Vice President, Chief Scientific Officer

Special Volunteer, Allergy & Immunology Training Program

Vice President, Clinical and Translational Medicine

Senior Director, Clinical and Translational Medicine

Chair (2015), Member (2012-2017) ABAI Board of Directors

Head, Lymphocyte Biology Unit, NIAID

Member, FDA Pulmonary-Allergy Drugs Advisory Committee

Associate Director, A&I Clinical Training Program

Staff Physician, Clinical Investigator, Laboratory of Allergic Disease

Commissioned Officer, retired @ O-6 grade

Calman Prussin

Sr. Director QA GMP Compliance

Director of Quality Late Phase/Commercial

Quality and Compliance Principal Consultant

Sr. Director Supplier Quality Management & GMP Auditing

Director, Supplier Quality Management & GMP Auditing

Associate Director, Quality Assessments

Sr. Manager Third Party QA

Manager Quality

QC Chemist

Herbert Vail

Sr. Director Global Clinical Supply Chain

Associate Director, Drug Supply

Director Supply Chain

Sr. Manager, Supply Chain

Associate Director, Materials Management

Planner, Manufacturing Operations

Sr. Analyst, Distribution & Logistics

Associate Manager, Supply Chain

Senior Financial Analyst

Kevin Cpim

Chief Financial Officer

CFO, VP of Finance

Christopher Courts

Head of Human Strategy

SVP Human Strategy & Operating Partner

Chief Human Strategy Officer

Advisor

Chief Human Resources Officer

Sr. Vice President Human Strategy

Vice President Global Human Resources

Vice President Human Resources

Sr. Director Human Strategy

Sr. Director Human Resources

Director Human Resources

Entrepreneural Human Strategist

Richard Fires

Chief Executive Officer

President Janssen Canada

Vice President Cardiovascular Sales and Marketing

Senior Vice President, Business Unit Leader

Vice President Medical Center Business Unit

Area Vice President Senior Care Business

Management Associate

Chief Executive Officer, Areteia Therapeutics

Jorge Bartolome

Senior Director, Clinical Operations

Director, Clinical Operations

Associate Director Site Management

Associate Director Clinical Operations

Manager, Clinical Operation

Senior Clinical Research Associate

Clinical Research Associate II

Clinical Research Coordinator II

Laboratory Technician/Blood Bank

Optician/Ophthalmic Technician

Laboratory Researcher/ Data Manager

Lab Assistant

Optician

Senior Director of  Clinical Operations at Areteia Therapeutics

Boontaricka Boonyapredee

Senior Director of Finance

Senior Accountant

Accounting Manager

Director of Finance

Controller/Director of Finance

Financial Analyst

Controller

Ericka Goss

Advisory Board Member

Associate Director, Clinical Operations Lead

Senior Clinical Study Manager

Senior Project Manager

Clinical Trial Manager

Clinical Project Manager

Clinical Research Associate

Assistant Clinical Research Associate

Senior Clinical Operations Coordinator

Senior Clinical Research Coordinator

Research Coordinator

Psychometrist

Associate Director, Clinical Operations

Cheryl Knipe

SVP & Chief Commercial Officer

Chief Commercial Officer & SVP Business development

Corporate VP Global Marketing, Inflammation & Immunology

VP Global Marketing, Inflammation & Immunology

Worldwide Vice-President Immunology

Worldwide VP - CNS

Worldwide Vice-President, Immunology

President, Consumer Medicines

VP Marketing, Consumer Medicines

Product Director, Tylenol

Product Director, Pepcid

SVP & Chief Commercial Officer Areteia Therapeutics

Mark Kreston

Areteia Therapeutics

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

news impact assignment basic	general	May 7, 2024 9:22 PM	0bd20b2f
public peers	general	May 7, 2024 9:22 PM	26e51737
news daily refresh	general	Aug 6, 2024 11:40 PM	efaa5232
news processing daily refresh	general	May 21, 2024 2:59 AM	3f7b89b2
news impact assignment daily	general
news processing basic	general	May 7, 2024 9:22 PM	b0130e46
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 7, 2024 9:22 PM	7e067685
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 7, 2024 9:22 PM	524edde5
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:ARETEIATX

Areteia Therapeutics